Aug 6, 2025 | Corporate and Press Releases
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, today announced that Xellera Therapeutics has been awarded a US$150,000 G-Rex® Grant to support the establishment of a highly efficient cGMP G-Rex® centric NK cell...
Apr 1, 2025 | Corporate and Press Releases
Cell Therapies and Xellera Therapeutics Forge Partnership: Signing a Memorandum of Understanding (MoU) to accelerate the development and accessibility of life-changing cell and gene therapies across the Asia-Pacific region. This partnership will offer new...
Feb 8, 2021 | Corporate and Press Releases
Xellera Therapeutics Launched Hong Kong’s First Current Good Manufacturing Practice (cGMP) Facility For Cell & Gene Therapy Products For Cell and Gene Therapy Products Hong Kong’s first-of-its-kind >8,500 ft² cGMP facilities for cell and gene therapy products...
